ライフサイエンスコーパス: tissue transplant

1 tory on his or her response to an allogeneic tissue transplant.

2 l produce a response similar to that after a tissue transplant.

3 ic subjects receiving human fetal pancreatic tissue transplants.

4 Immune rejection continues to threaten all tissue transplants.

5 Because of limitations associated with fetal tissue transplants, a clone (1RB3AN27) of simian virus 4

6 Thus, thymic tissue transplanted across an SLA class I barrier can en

7 Axons from embryonic entorhinal tissue transplanted adjacent to the denervated area are

8 Experimental strategies using tissue transplants and cell culture models have explored

9 understanding of the antigenicity of complex tissue transplants and mechanisms to promote graft accep

10 sses eGFP uniformly, and that can be used in tissue transplants and processed by in situ hybridizatio

11 rtant role in generating immune responses to tissue transplants and tumors in vivo.

12 e different types of HIS mice based on human tissues transplanted and sources of the tissues.

13 he induction of immunologic tolerance of the tissue transplants because tolerance would eliminate the

14 Somitic tissue transplanted between axial levels retains both or

15 tory response to an allogeneic or xenogeneic tissue transplant by the recipient is complex and includ

16 Tissue transplants demonstrate that fgf3 activity is spe

17 teristics that were associated with organ or tissue transplants during childhood.

18 Classical tissue transplant experiments in the chick and recent st

19 of tissue that is more site appropriate than tissue transplanted from the palate.

20 Naive mice were not infected by tissue transplants from antibiotic-treated mice even tho

21 m cell-derived cardiomyocytes (hiPSC-CMs) as tissue transplants in regenerative medicine depends on c

22 em cell transplants differ from conventional tissue transplants insofar as not all alloantigens are r

23 omponents of tissue destruction of human GPA tissue transplanted into immunodeficient mice.

24 pro-myelomonocytic U937 cells into synovial tissue transplanted into SCID mice.

25 ally normal and unrelated allografted neural tissue transplanted into the brain of affected HD patien

26 tau pathology can manifest in healthy neural tissue transplanted into the brains of patients with two

27 account for the capacity of neonatal retinal tissue transplanted into the eye to alter the systemic a

28 rated using a novel approach targeting human tissues, transplanted into SCID mice, directly by in viv

29 the establishment of vascularized composite tissue transplant models in small mammals.

30 tical sciences in genetically engineered and tissue transplanted mouse models of disease.

31 This procedure, as well as other composite tissue transplants, offers the potential for correcting

32 n explanation for one of the most successful tissue transplants performed in humans.

33 cyclosporin A (CsA) are widely used to treat tissue transplant rejection and acute graft-versus-host

34 erefore a target for autoimmunity disorders, tissue transplant rejection and T-cell malignancies.

35 ases, ischemic reperfusion injury (IRI), and tissue transplant rejection.

36 Implantable cell therapies and tissue transplants require sufficient oxygen supply to f

37 cells are developed (e.g., stem cell-derived tissue), transplanting them in a durable device could ob

38 m (CNS), somites, and notochord by organizer tissue transplanted to the ventral side of host embryos.

39 Allogeneic tissues transplanted to mice treated with CD4- and CD8-s

40 gical rejection classification of urogenital tissue transplants using a new rat heterotopic penile tr

41 nvelope could theoretically determine, as in tissue transplants, whether HIV-1 is "rejected" by expos